Position of the Transparency Council – EpiPen Jr. (epinephrine) and EpiPen Senior (epinephrine)
At its meeting on 13 May 2025, the Transparency Council adopted position No. 60/2025 on the appraisal of drugs EpiPen Jr. (epinephrine) and EpiPen Senior (epinephrine) are indicated for the treatment of severe allergic reactions (anaphylaxis) to insect stings or bites, food, drugs, or other allergens, as well as for idiopathic or exercise-induced anaphylaxis